Seo Bo-Rim, Yoo Chae-Bin, Park Hee-Juhn, Choi Jong-Won, Seo Kyungwon, Choi Seung-Ki, Lee Kyung-Tae
College of Pharmacy, Kyung-Hee University, Dongdaemun-Ku, Seoul, Korea.
Biol Pharm Bull. 2004 Oct;27(10):1594-8. doi: 10.1248/bpb.27.1594.
The present work was performed to investigate the effects of saucernetin-8 on proliferation and differentiation of human leukemia HL-60 cells as well as the underlying mechanisms for these effects. Saucernetin-8 exhibited a potent antiproliferative activity against HL-60 cells. This compound was also found to be a potent inducer of differentiation in human leukemia derived HL-60 cells through the examination of differentiation markers, as assessed by nitroblue tetrazolium reduction test, esterase activity assay, phagocytic activity assay, morphology change, and expression of CD14 and CD66b surface antigens. These results suggest that saucernetin-8 induces the differentiation of human leukemia cells to granulocytes and monocytes/macrophages lineage. Moreover, DNA flow-cytometry indicated that saucernetin-8 induced a G1 phase arrest of HL-60 cells. The protein and mRNA expression levels of p21 were up-regulated during saucernetin-8-dependent HL-60 cell differentiation, whereas the level of c-myc was down-regulated. Taken together, our results suggest that saucernetin-8 may have potential as a therapeutic agent in human leukemia.
开展本研究旨在探讨山奈酚-8对人白血病HL-60细胞增殖和分化的影响及其作用机制。山奈酚-8对HL-60细胞表现出强大的抗增殖活性。通过硝基蓝四氮唑还原试验、酯酶活性测定、吞噬活性测定、形态学变化以及CD14和CD66b表面抗原表达评估等分化标志物检测,发现该化合物还是人白血病来源的HL-60细胞分化的有效诱导剂。这些结果表明,山奈酚-8可诱导人白血病细胞向粒细胞和单核细胞/巨噬细胞谱系分化。此外,DNA流式细胞术表明,山奈酚-8诱导HL-60细胞G1期阻滞。在山奈酚-8依赖的HL-60细胞分化过程中,p21的蛋白质和mRNA表达水平上调,而c-myc水平下调。综上所述,我们的结果表明,山奈酚-8可能具有作为人白血病治疗药物的潜力。